Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (2): 163-165.doi: 10.3736/jcim20080211

• Original Experimental Research • Previous Articles     Next Articles

Matrine and anti-tumor drugs in inhibiting the growth of human lung cancer cell line

Mu-yun Zhu(), Zheng-hua Jiang, Yuan-wen Lu, Yuan Guo, Jun-ji Gan   

  1. Department of Respiratory Diseases, Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu Province 225001, China
  • Received:2007-05-16 Online:2008-02-20 Published:2008-02-15
  • Contact: ZHU Mu-yun E-mail:yzszmy@163.com

objective: To study the activities of matrine and anti-tumor drugs on SPCA/Ⅰ human lung adenocarcinoma cell line.

Methods: Suppression effects of different concentrations of matrine and matrine combined with anti-tumor drugs on lung cancer cells were measured by methyl thiazolyl tetrazolium (MTT) colorimetric assay.

Results: Different concentrations of matrine could inhibit the growth of SPCA/Ⅰ human lung adenocarcinoma cells and there was a positive correlation between the inhibition rate and the drug concentration. Different concentrations of matrine combined with anti-tumor drugs had higher growth inhibition rate than anti-tumor drugs alone.

Conclusion: Matrine has direct growth suppression effect on SPCA/Ⅰ human lung adenocarcinoma cells and matrine conbined with anti-tumor drugs shows a significant synergistic effect on tumor cells.

Key words: matrine, combination chemotherapy, lung cancer

CLC Number: 

  • R734.2

Table 1

Growth inhibitory rate of anti-tumor drugs alone and matrine combined with anti-tumor drugs ($\bar{x}$±s, %)"

Group Growth inhibitory rate
1 PPC HCPT-treated 55.88±5.93
1 PPC HCPT plus 0.1 PPC matrine-treated 84.01±2.92**
1 PPC HCPT plus 1 PPC matrine-treated 88.81±4.11**
1 PPC VP-16-treated 66.10±1.29
1 PPC VP-16 plus 0.1 PPC matrine-treated 80.06±4.76
1 PPC VP-16 plus 1 PPC matrine-treated 87.37±3.07△△
[1] Wang TJ, Li SP, Jian JR , et al. Advances in the studies of anti-tumour activity of alkaloids in Radix Sophorae Flavescentis(Kushen)[J]. Zhongguo Shi Yan Fang Ji Xue Za Zhi, 2004,10(4):53-55
王铁军, 李绍平, 简家荣 , 等. 苦参碱抗肿瘤作用研究进展[J]. 中国实验方剂学杂志, 2004,10(4):53-55
[2] Dai ZJ, Wu WY, Wang XJ , et al. Effect of Fufangkushen Injection on immunity of patient with metaphase and late lung squamous carcinoma treated with chemotherapy[J]. Beijing Zhong Yi Yao Da Xue Xue Bao, 2005,28(6):77-79
代志军, 仵文英, 王西京 , 等. 复方苦参注射液对中晚期肺鳞癌化疗患者免疫功能的影响[J]. 北京中医药大学学报, 2005,28(6):77-79
[3] Chen YH, Yin SS, Tian SX , et al. Effect of Compound Kushen on T cell subgroup of malignant tumor[J]. Zhong Liu Yan Jiu Yu Lin Chuang, 1999,11(3):191
陈耀华, 尹时生, 田喜顺 , 等. 复方苦参对恶性肿瘤T细胞亚群的影响[J]. 肿瘤研究与临床, 1999,11(3):191
[4] Li ZY, Shi KH, Ci YY . Therapeutic effect of Compound Kushen Injection on 28 patients with lung cancer after discontinued radiotherapy[J]. Zhong Yi Yao Xin Xi, 2001,18(6):30-31
doi: 10.3969/j.issn.1002-2406.2001.06.015
李竹英, 石克华, 慈玉莹 . 复方苦参注射液对28例肺癌放疗中断后近期疗效观察[J]. 中医药信息, 2001,18(6):30-31
doi: 10.3969/j.issn.1002-2406.2001.06.015
[5] Chen JQ, Tang YH, Wu XA . Therapeutic observation on effect of compound Kushen Injection on pain caused by cancer[J]. Sichuan Zhong Liu Fang Zhi, 2002,15(4):236-237
陈建清, 唐耀华, 吴晓安 . 复方苦参注射液治疗癌痛的疗效观察[J]. 四川肿瘤防治, 2002,15(4):236-237
[1] Goulnar Kasymjanova, Anh-Thi Tran, Victor Cohen, Carmela Pepe, Lama Sakr, David Small, Jason Scott Agulnik, Robert Thomas Jagoe. The use of a standardized Chinese herbal formula in patients with advanced lung cancer: A feasibility study. Journal of Integrative Medicine, 2018, 16(6): 390-395.
[2] Shui-jie Shen, Yong-hong Zhang, Xiao-xia Gu, Shui-ju Jiang, Ling-jun Xu. Yangfei Kongliu Formula, a compound Chinese herbal medicine, combined with cisplatin, inhibits growth of lung cancer cells through transforming growth factor-β1 signaling pathway. Journal of Integrative Medicine, 2017, 15(3): 242-251.
[3] Zhong-liang Liu, Wei-rong Zhu, Wen-chao Zhou, Hai-feng Ying, Lan Zheng, Yuan-biao Guo, Jing-xian Chen, Xiao-heng Shen. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: A systematic review and meta-analysis. Journal of Integrative Medicine, 2014, 12(4): 346-358.
[4] Jing Guo, Ju-yong Wang, Zhan Zheng, Qing Wang, Chang-sheng Dong . Effects of Chinese herbal medicine Feiyanning Decoction on the ratio of CD4+CD25+ regulatory T cells and expression of transcription factor Foxp3 in mice bearing Lewis lung carcinoma. Journal of Chinese Integrative Medicine, 2012, 10(5): 584-590.
[5] Wan Su , Zhen-ye Xu. Gene polymorphism and physical constitution theory: Starting point of exploring syndromes of lung cancer. Journal of Chinese Integrative Medicine, 2010, 8(1): 15-19.
[6] Wen-xiang Zhou, Wen-bin Zheng, Xiao-mei Huang, Ying Zhang, Xiang-zhi Nie, Hong-bing Li, Da He, Lan-qian Xie. Effects of oxymatrine on microinflammatory state in patients undergoing continuous hemodialysis: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2009, 7(8): 736-740.
[7] Wen-hua Ma , Kai-nan Duan, Min Feng, Bin She, Yan Chen, Rui-ming Zhang. Aidi Injection as an adjunct therapy for non-small cell lung cancer: A systematic review. Journal of Chinese Integrative Medicine, 2009, 7(4): 315-324.
[8] Hai-xia Yan, Yi-qin Wang , Hui-rong Zhu , Li-hong Zhao , Ci-bin Lin , Qi-miao Gong, Peng-nian Liu . Changes of tongue and pulse parameters in 50 lung cancer patients treated with integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2009, 7(3): 218-222.
[9] Jian-hui Tian, Zhi-ming Shi, Zhi-yi Zhou, Yun-sheng Huang, Lin Wang. Effects of Feiji Formula on lung cancer metastasis in mice. Journal of Chinese Integrative Medicine, 2008, 6(8): 827-829.
[10] Jie Shen, Ge-ping Qu, Qing-yu Xiu, Bing Li. Effects of arsenic trioxide on apoptosis and proliferation of human lung cancer cells under hypoxia. Journal of Chinese Integrative Medicine, 2008, 6(3): 274-277.
[11] Tie Chong​, Jian-qiang Niu​, Zi-ming Wang​, Jun-jun She​, Chen Huang​. Effects of matrine on proliferation and apoptosis of human renal cell carcinoma cell line GRC-1. Journal of Chinese Integrative Medicine, 2006, 4(4): 388-391.
[12] Kai-wen Hu, Fen Wang, Yang Cao, Xiu-lan He, Ming-huan Zuo, Wen-qiang Chen. Risk factors of traditional Chinese medical syndromes in moderate and advanced lung cancer patients with concurrent fungal pneumonia. Journal of Chinese Integrative Medicine, 2004, 2(5): 337-339.
[13] Shang-cai Yu, Zu-xi Gu, Ju-ying Gu, Jin-ying Yang, Xiong Lu, Hui-zheng Xu. Effect of oxymatrine on pathological change in brain tissue of newborn mice infected by cytomegalovirus. Journal of Chinese Integrative Medicine, 2004, 2(3): 205-207.
[14] Wei-ming Fang, Wei-ping Wang, Bing-wei Yan, Jian-yuan Zhou. Treatment of non-small-cell lung cancer with chemotherapy and Sansheng Huatan Decoction. Journal of Chinese Integrative Medicine, 2004, 2(2): 103-105.
[15] Zhen-ye Xu. Evidence-based medicine and treatment of lung cancer. Journal of Chinese Integrative Medicine, 2003, 1(2): 151-154.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[2] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[3] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[4] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[5] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[6] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022
[7] Yan-bo Zhu , Qi Wang, Cheng-yu Wu, Guo-ming Pang, Jian-xiong Zhao, Shi-lin Shen, Zhong-yuan Xia , Xue Yan . Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity. Journal of Chinese Integrative Medicine, 2010, 8(11): 1023-1035
[8] Bing Hu , Hong-mei An , Ke-ping Shen , Qin Du. Senescence-inducing effects of Chinese herbal medicine Tenglong Buzhong Decoction on human colon carcinoma LS-174-T cells and the mechanism. Journal of Chinese Integrative Medicine, 2010, 8(11): 1048-1052
[9] Ya-bing Zhou, Jian-er Yu, Jie Wu, Li Bai, Li-li Huo, Xin-guang Zhang, Li-qing Li . Effects of Chinese herbal medicine Bushen Gubiao Recipe on toll-like receptor 4 and CD4 +CD25 +foxp3 +regulatory T cells in mice with recurrent respiratory tract infections. Journal of Chinese Integrative Medicine, 2010, 8(11): 1053-1059
[10] Tao Wang , Feng Qin. Effects of Chinese herbal medicine Xiaoyao Powder on monoamine neurotransmitters in hippocampus of rats with postpartum depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1075-1079